MarketInOut Stock Screener Log In | Sign Up
 

Amphastar Pharmaceuticals Inc

IEX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/18/2026 15:59
Amphastar Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization735.91 mln
Float32.84 mln
Earnings Date08/06/2026

EPS

1.66
Decent

P / E

10.36
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.72
Likely reliable

1-Year Forecast

23.33
Strong upside

Relative Strength

3 / 100
Severely lagging

Business Description

Amphastar Pharmaceuticals is a drug company based in Rancho Cucamonga, California, that develops and sells a broad range of medicines across the United States, China, and France. Its products cover several medical needs, including emergency treatments for severe low blood sugar and opioid overdose, respiratory relief for asthma and lung disease, and solutions for conditions such as iron deficiency, osteoporosis, and abnormal immune responses. The company produces both branded and generic medicines in injectable, inhaled, and nasal spray forms, as well as the raw pharmaceutical ingredients used to make insulin. Founded in 1996, Amphastar serves patients requiring both routine and urgent medical care.

Key Fundamentals

EPS1.66
P/E10.36
ROE10.30
RPS15.21
ROIC7.49
ROA4.84
Interest Cover4.53
EBITDA, mln193
EV / EBITDA6.38
EV / EBIT9.58
Revenue, mln721
EV / Revenue1.71

Financial Strength

Altman Z-Score2.18
Piotroski F-Score 6 / 9
Beneish M-Score-2.72
Price to Intrinsic Value0.37
Price to Lynch Fair Value0.36
Price to Graham Number1.19
1-Year Target Price23.33
Shiller PE Ratio12.87
Short Ratio8.20
Short % of Float16.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.78% 18 / 100   
1 Month -24.83% 5 / 100   
2 Months -39.88% 4 / 100   
6 Months -34.77% 13 / 100   
1 Year -29.28% 18 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us